Legal Representation
Attorney
Jana E. Harris
USPTO Deadlines
Next Deadline
364 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-10)
Due Date
November 10, 2026
Grace Period Ends
May 10, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 10, 2020 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Oct 6, 2020 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 29, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 21, 2020 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Sep 17, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 16, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 16, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 14, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 14, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 14, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 10, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 10, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 12, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of rare diseases
First Use Anywhere:
20190400
First Use in Commerce:
20190400
Classification
International Classes
035